Ginkgo Smart

Ginkgo Smart

Irwin Naturals4.6 (2,504 ratings)
Format:Softgel Quantity: 120 Softgel(s) · 60 servings
Goals

Product analysis

43 out of 100

Ginkgo Smart combines ginkgo with other ingredients for attention and memory support, though ginkgo findings are mixed. Unidentified powder and extract preparations make the expected benefit uncertain.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

Most ingredient forms are unspecified, including the omega-3 form. The named fish and botanical ingredients do not establish the quality of the full combination.

Ingredient Transparency65

Most amounts are listed, but few ingredient forms are identified. Several composition details are clear, while one part of the formula remains uncertain.

Value For Money28

The cost is unfavorable when judged by the amount of deanol. Value for the other ingredients remains uncertain, including omega-3 without a usable EPA and DHA comparison.

Customer Satisfaction83

Customer ratings are generally very positive. A substantial number of ratings gives a broad view of customer satisfaction.

Product Focus41

Ginkgo is the main ingredient linked to attention and memory, with mixed findings. The smaller supporting amounts do not establish improved everyday work output.

Format
Softgel
Container
120 Softgel(s)
Per serving
$0.58
Customer rating
4.6 · 2,504 ratings
Report analysis

Goals

Mental Focus
Impact
Moderate effect
C Ingredient FitD- PathwaysC EvidenceA+ Formulation Logic
Choline · 30 mgAcetyl L-Carnitine · 40 mg
Study evidence
Choline Supportive 22 studies
Ginkgo Supportive 28 studies
Cognitive Support
Impact
Moderate effect
C+ Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Choline · 30 mgAcetyl L-Carnitine · 40 mg
Study evidence
Choline Supportive 76 studies
Deanol No effect 2 studies
Ginkgo Supportive 87 studies
Productivity Boost
Impact
Moderate effect
C Ingredient FitF PathwaysD+ EvidenceA+ Formulation Logic
Omega-3 · 180 mgAcetyl L-Carnitine · 40 mgAcetyl L-Carnitine · 40 mg
Study evidence
Ginkgo Supportive 20 studies
Omega-3 Supportive 46 studies
Brain Health
Impact
Moderate effect
C Ingredient FitD- PathwaysC- EvidenceA+ Formulation Logic
Study evidence
Ginkgo Supportive 90 studies
Impact
Limited evidence
F Ingredient FitF PathwaysF EvidenceB Formulation Logic
Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per servingScore
Calories
15 Calorie(s)
Total Fat
1 Gram(s)
Cholesterol
5 mg
Protein
1 Gram(s)
Choline (Choline Bitartrate)
30 mg 44
Fish Oil (Anchovy, Sardine)
600 mg 6
Omega-3 Fatty Acids
180 mg 16
Ginkgo, Powder (Ginkgo biloba, Powder)
400 mg 58
Ginkgo Leaf Extract
120 mg 58
Flavone Glycosides
28.8 mg
Terpene Lactones
7.2 mg
Dimethylaminoethanol Bitartrate
40 mg 73
Trimethylglycerine Hydrochloride
25 mg
Acetyl-L-Carnitine (Acetyl-L-Carnitine Hydrochloride)
40 mg 55
Alpha-Lipoic Acid
15 mg
Velvet Bean seed extract
10 mg
Toothed Clubmoss extract
1 mg
BioPerine Complex
6 mg
Bioperine Black Pepper extract (Piperine)
0 NP
Ginger extract (Gingerols)
0 NP
Adults 18–50 Women
Report overview
Deanol · 40 mg OverallScore73
A+ Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyF Value
A serving provides 40 mg of active DMAE at a very high cost for that amount. It names DMAE bitartrate as the form. The information includes a DMAE-related safety warning.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

The active DMAE amount is stated, and the source is DMAE bitartrate.
Deanol Form Specificity
The form is named as DMAE bitartrate.
Active Deanol Yield Transparency
The active DMAE amount is stated as 40 mg per serving.

Dose, Safety & Label Transparency78

40 mg is a relatively modest amount of active DMAE per serving. The information includes a DMAE-related safety warning.
Dosage Appropriateness
40 mg is a relatively modest amount of active DMAE per serving.
Specific Safety Warnings
The information includes a DMAE-related safety warning.

Value10

The cost is very high for the amount of active DMAE provided.
Price Per 100mg Active Deanol
The cost is very high for the amount of active DMAE provided.
D+ Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyF Value
Each serving provides 30 mg of choline from Choline Bitartrate, with a high cost for the amount supplied. A flagged additive is present; the specific ingredients are not identified in the available details.
How this ingredient is rated

Active Ingredient Quality & Bioavailability53

Choline Bitartrate is a standard form used for choline throughout the body. A flagged additive is present; the specific ingredients are not identified in the available details.
Choline Form Efficacy & Bioavailability
Choline Bitartrate is a standard form used for choline throughout the body.
Formula Purity & Excipient Quality
A flagged additive is present; the specific ingredients are not identified in the available details.

Dose, Safety & Label Transparency47

Each serving provides 30 mg of choline. The label states the choline source.
Choline Dose by Declared Basis
Each serving provides 30 mg of choline.
Elemental Yield Transparency
The label states the choline amount and names Choline Bitartrate as its source.

Value20

The cost relative to the amount of choline is high.
Price per 100 mg of Declared Choline Basis
The cost relative to the amount of choline is high.
A Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value
The selected serving lists 40 mg of acetyl L-carnitine HCl. The cost of the product per 500 mg of acetyl L-carnitine is very high. A manufacturing or purity claim is recorded, though its details are not specified.
How this ingredient is rated

Active Ingredient Quality & Bioavailability94

The form is acetyl L-carnitine HCl. A manufacturing or purity claim is recorded, though its details are not specified.
ALCAR vs. Standard Carnitine Form
The ingredient is acetyl L-carnitine HCl.
Advanced Sourcing and Salt Specificity
The form is acetyl L-carnitine HCl. A manufacturing or purity claim is recorded, though its details are not specified.

Dose, Safety & Label Transparency44

The selected serving lists 40 mg of acetyl L-carnitine HCl.
Clinical Dosage Efficacy
The selected serving lists 40 mg of acetyl L-carnitine HCl.
Label Transparency and Proprietary Blends
The selected serving lists 40 mg of acetyl L-carnitine HCl.

Value0

The cost of the product per 500 mg of acetyl L-carnitine is very high.
Price per 500mg Acetyl L-Carnitine
The cost of the product per 500 mg of acetyl L-carnitine is very high.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  2. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  3. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  4. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  5. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  6. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  7. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  8. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  9. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  10. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  11. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  12. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  13. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M · Clinical therapeutics · 2003
    Randomized trial261 participantsCognitive Support forCholine
  14. Association of dietary choline intake with incidence of dementia, Alzheimer disease, and mild cognitive impairment: a large population-based prospective cohort study.
    Niu YY; Yan HY; Zhong JF; Diao ZQ; Li J; Li CP; Chen LH; Huang WQ; Xu M; Xu ZT; Liang XF; Li ZH; Liu D · The American journal of clinical nutrition · 2025
    Cohort study125,594 participantsCognitive Support forCholine
  15. Choline intake during pregnancy and child cognition at age 7 years.
    Boeke CE; Gillman MW; Hughes MD; Rifas-Shiman SL; Villamor E; Oken E · American journal of epidemiology · 2013
    Cohort study895 participantsCognitive Support forCholine
  16. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Sohn M; Park YH; Lim S · Diabetes, obesity & metabolism · 2025
    Randomized trial36 participantsCognitive Support forCholine
  17. Maternal choline supplementation mitigates alcohol exposure effects on neonatal brain volumes.
    Warton FL; Molteno CD; Warton CMR; Wintermark P; Lindinger NM; Dodge NC; Zöllei L; van der Kouwe AJW; Carter RC; Jacobson JL; Jacobson SW; Meintjes EM · Alcoholism, clinical and experimental research · 2022
    Randomized trial52 participantsCognitive Support forCholine
  18. Senile dementia: treatment with deanol.
    Ferris SH; Sathananthan G; Gershon S; Clark C · Journal of the American Geriatrics Society · 1977
    Single-arm trial14 participantsCognitive Support forDeanol
  19. Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies.
    Blin O; Audebert C; Pitel S; Kaladjian A; Casse-Perrot C; Zaim M; Micallef J; Tisne-Versailles J; Sokoloff P; Chopin P; Marien M · Psychopharmacology · 2010
    Randomized trial24 participantsCognitive Support forDeanol
  20. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo